Scientists at the Institute of Cancer Research and the Royal Marsden NHS Foundation Trust used a drug made from a genetically modified form of herpes simplex — the cold sore virus — to attack tumors in cancer patients' bodies, developing a cutting-edge form of cancer therapy in the process.
While experts caution that more follow up studies will be needed, the treatment has seemingly already saved the life of at least one patient,That patient, Krzysztof Wojkowski from West London, underwent the experimental therapy after he received a diagnosis of salivary gland cancer 2017.. "It was devastating, so it was incredible to be given the chance to join the trial."
Many experimental treatments fail. But this one appears to have been the exception, at least for now — which is extraordinary news for Wojnowski, and just may help blaze a trail to help others as well. "I had injections every two weeks for five weeks which completely eradicated my cancer," Wojnowski told theThe virus injections, known as RP2, are administered directly into the tumor.
I am no attorney, but it seems to me you could ask for another opinion, this is life and death literally ,you should be able to ask for a neutral Dr's opinion
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: IntEngineering - 🏆 287. / 63 Read more »
Source: hackernoon - 🏆 532. / 51 Read more »
Source: NatureMedicine - 🏆 451. / 53 Read more »